8-96251090-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_015942.5(MTERF3):c.493G>T(p.Asp165Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015942.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTERF3 | NM_015942.5 | c.493G>T | p.Asp165Tyr | missense_variant | Exon 4 of 8 | ENST00000287025.4 | NP_057026.3 | |
MTERF3 | NM_001286643.1 | c.493G>T | p.Asp165Tyr | missense_variant | Exon 4 of 9 | NP_001273572.1 | ||
MTERF3 | XM_011517054.3 | c.154G>T | p.Asp52Tyr | missense_variant | Exon 4 of 8 | XP_011515356.1 | ||
MTERF3 | NM_001362964.1 | c.-78G>T | 5_prime_UTR_variant | Exon 4 of 8 | NP_001349893.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTERF3 | ENST00000287025.4 | c.493G>T | p.Asp165Tyr | missense_variant | Exon 4 of 8 | 1 | NM_015942.5 | ENSP00000287025.3 | ||
MTERF3 | ENST00000523821.5 | c.493G>T | p.Asp165Tyr | missense_variant | Exon 4 of 9 | 1 | ENSP00000429400.1 | |||
MTERF3 | ENST00000522822.5 | c.130G>T | p.Asp44Tyr | missense_variant | Exon 2 of 6 | 2 | ENSP00000430138.1 | |||
MTERF3 | ENST00000524341.5 | c.-78G>T | 5_prime_UTR_variant | Exon 2 of 5 | 3 | ENSP00000429267.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.493G>T (p.D165Y) alteration is located in exon 4 (coding exon 3) of the MTERF3 gene. This alteration results from a G to T substitution at nucleotide position 493, causing the aspartic acid (D) at amino acid position 165 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at